13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

AMRZ Stock Analysis & AI Quality Score

AI stock analysis and institutional research for Amrize Ltd (AMRZ), a Materials sector company. AMRZ is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Based on the latest XBRL financial filings (Q1 2026), Amrize Ltd reports quarterly revenue of $2.2B, net income of $-116.0M, an operating margin of -3.5%. Top institutional holders of AMRZ by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, BlackRock,, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, based on the most recent SEC filings. AMRZ trades on the NYSE exchange and files with the SEC under CIK 2035989. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AMRZ daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Amrize Ltd directly from SEC EDGAR.

Revenue

Q1 2026

$2.2B

Net Income

Q1 2026

$-116.0M

Free Cash Flow

Q1 2026

$-1.2B

Operating Margin

Q1 2026

-3.5%

ROIC

Q1 2026

-0.4%

D/E Ratio

Q1 2026

0.46

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+1.2% YoY
$11.81BFY 2025
FY22 FY23 $11.68BFY25 $11.81B

Net Income

+24.0% YoY
$1.19BFY 2025
FY22 FY23 $956.0MFY25 $1.19B

Operating Income

+1.0% YoY
$1.91BFY 2025
FY22 FY23 $1.89BFY25 $1.91B

EPS (Diluted)

+23.7% YoY
$2.14FY 2025
FY22 FY23 $1.73FY25 $2.14

Total Assets

$24.25BFY 2025
FY22 FY23 FY25 $24.25B

Total Debt

$5.27BFY 2025
FY22 FY23 FY25 $5.27B

Op. Cash Flow

+8.4% YoY
$2.21BFY 2025
FY22 FY23 $2.04BFY25 $2.21B

AI Insight: AMRZ Financial Trends

Q1 2026 acquisition debt surge to $6,046M flips Amrize to operating loss, erasing three quarters of cash-generation momentum.

Revenue fell from $3,675M in Q3 2025 to $2,178M in Q1 2026, a 41% sequential decline over two quarters.

Operating income swung from $778M in Q3 2025 to a loss of $76M in Q1 2026, marking the first operating loss in the dataset.

Operating cash flow reversed sharply from a $1,804M inflow in Q4 2025 to a $896M outflow in Q1 2026.

Equity remained relatively stable, rising from $12,434M in Q2 2025 to $13,094M in Q1 2026, despite the net loss.

Total debt jumped from $547M in Q3 2025 to $6,046M in Q1 2026 — a 10x spike likely signaling a major acquisition.

Sustained negative operating cash flow alongside elevated debt raises near-term liquidity and debt-service risk.

Whether Q1 2026 seasonality or acquisition integration costs explain the revenue trough will be critical to monitor next quarter.

AI Insight: AMRZ Ratio Trends

Amrize swung to negative operating margin of -3.5% in Q1 2026, reversing sharply from 21.2% just two quarters prior.

Operating margin collapsed from 21.2% in Q3 2025 to -3.5% in Q1 2026 — a 24.7pp deterioration in two quarters.

ROIC turned negative at -1.6% in Q1 2026, down from 23.1% in Q3 2025, signaling capital destruction.

D/E ratio spiked to 0.46 in Q1 2026 from near-zero (0.04) in Q3 2025, indicating a significant leverage increase.

Net profit margin fell from 14.8% in Q3 2025 to -5.3% in Q1 2026, the first negative reading in available data.

D/E jumped from 0.04 to 0.46 in one quarter — monitor whether this reflects new debt or one-off restructuring.

Q1 2026 losses may reflect seasonality; confirm whether Q2 2026 margins recover toward Q3 2025 levels.

ROE turned negative at -3.5% in Q1 2026 — watch for sustained negative returns eroding book value.

Get alerted when AMRZ's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Amrize Ltd including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of AMRZ

Put AMRZ on your watchlist

Track score changes the day Amrize Ltd files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is AMRZ a good stock to buy?

13F Pro's AI-powered analysis of Amrize Ltd (AMRZ) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Materials sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for AMRZ are available on the AMRZ stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own AMRZ?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling AMRZ. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Amrize Ltd's investment landscape.